MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special storage conditions.

Provenance

This compatibility recommendation is derived from Ebixa 10mg tablets (Lundbeck Ltd).

Stability Notes

No special storage conditions.

Provenance

This compatibility recommendation is derived from Ebixa 15mg tablets (Lundbeck Ltd).

Stability Notes

No special storage conditions.

Provenance

This compatibility recommendation is derived from Ebixa 20mg tablets (Lundbeck Ltd).

Stability Notes

No special storage conditions.

Provenance

This compatibility recommendation is derived from Ebixa 5mg tablets (Lundbeck Ltd).

Stability Notes

Store in the original package in order to protect from light and moisture. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Edarbi 20mg tablets (Takeda UK Ltd).

Stability Notes

Store in the original package in order to protect from light and moisture. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Edarbi 40mg tablets (Takeda UK Ltd).

Stability Notes

Store in the original package in order to protect from light and moisture. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Edarbi 80mg tablets (Takeda UK Ltd).

Stability Notes

This medicinal product does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Diamicron 30mg MR tablets (Servier Laboratories Ltd).

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Edurant 25mg tablets (Janssen-Cilag Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.